About Us
The Princess Margaret (PM) Cancer Centre is the largest integrated cancer research, teaching and treatment centre in Canada. Its research institute, formerly known as the Ontario Cancer Institute (OCI), includes internationally recognized researchers, cutting-edge research infrastructure and the Campbell Family Institute for Breast Cancer Research. The Centre focuses on cancer research across various fields including genomics, informatics, molecular biology, signalling, structural biology, health services and biophysics. PM’s laboratories and facilities are primarily located at the Centre itself (610 University Avenue) and at the Princess Margaret Cancer Research Tower (in the MaRS Centre).

PM Cancer Centre’s researchers are grouped into the following categories based on their research program:
  • Biodiscovery & Drug Development
  • Cancer Genomics, Epigenetics & Bioinformatics
  • Immunotherapy
  • Psychosocial Aspects of Cancer
  • Stem Cells in Cancer
  • Tumour biology & Imaging
About Us

The Princess Margaret (PM) Cancer Centre is the largest integrated cancer research, teaching and treatment centre in Canada. Its research institute, formerly known as the Ontario Cancer Institute (OCI), includes internationally recognized researchers, cutting-edge research infrastructure and the Campbell Family Institute for Breast Cancer Research. The Centre focuses on cancer research across various fields including genomics, informatics, molecular biology, signalling, structural biology, health services and biophysics. PM’s laboratories and facilities are primarily located at the Centre itself (610 University Avenue) and at the Princess Margaret Cancer Research Tower (in the MaRS Centre).

PM Cancer Centre’s researchers are grouped into the following categories based on their research program:

  • Biodiscovery & Drug Development
  • Cancer Genomics, Epigenetics & Bioinformatics
  • Immunotherapy
  • Psychosocial Aspects of Cancer
  • Stem Cells in Cancer
  • Tumour biology & Imaging
PM Research Council on Oncology (RCO)
Director, ResearchMitsu Ikura (Interim)
Executive CommitteeMing-Sound Tsao
Camilla Zimmermann
Naoto Hirano
Thomas Kislinger
Vuk Stambolic
Aaron Schimmer
Gang Zheng
Mathieu Lupien
Head, Psychosocial OncologyGary Rodin
Medical Director, Laboratory Medicine ProgramRunjan Chetty
Medical Director, Cancer ProgramMary Gospodarowicz
Head, Radiation MedicineFei-Fei Liu
Head, Medical Oncology and HematologyAmit Oza (Interim)
Chief, Surgical OncologyGelareh Zadeh
Head, Cancer Clinical Research UnitAmit Oza
Senior Vice President, UHN and Executive Lead, PM Cancer CentreMarnie Escaf
Executive Vice President, Science and ResearchBradly Wouters

 

Appointments Committee
  • Categories of Appointment

    Categories of Appointment

    At Princess Margaret there are four types of academic appointments depending on your protected time for research.  Below is a detailed description of each type of academic appointment.

    In general, the categories of Scientist and Senior Scientist are designed for individuals whose primary commitment within the Institute is research.  Normally this will be reflected by a substantial time commitment to research, but will also be obvious from their research accomplishments and overall academic profile.

    a) Scientist
    These are initial appointments for researchers who have demonstrated the potential to develop independent research programs. Such individuals will have undergone significant research training and will have the goal to establish a strong, internationally recognized research program. It is expected that during this appointment, these individuals will acquire peer-reviewed funds, produce independent work that is published in recognized peer-reviewed journals, and participate in the scientific life of the Institute.

    Individuals will be appointed to the Scientist category for a 3-year term, and are subject to a review at the end of this term (S3 review).  If the committee recommends passing the candidate, they will grant a second 3-year term.  At the 6-year mark, the scientist will undergo an S6 promotional review.  This type of review is conducted with the rigor of a tenure review to determine whether researchers should be appointed for a 5-year renewable term as a Senior Scientist.  

    b) Senior Scientist
    These are accomplished individuals who have established strong, extramurally funded research programs and have made significant and original contributions. Their productivity must be well documented by publications in top peer-reviewed journals, grants, invitations, awards, etc. The Senior Scientist will have established a research program that is capable of achieving long range goals and is based upon stable and consistent grant support. These individuals will make significant contributions to the life of the Institute and to the scientific community at large. They will have established reputations as Scientists of significance both within and outside of the Institute. Senior Scientists are appointed for 5-year terms that are renewable subject to review

    c) Affiliate Scientist

    The category of Affiliate Scientist is designed for clinical and basic researchers within the cancer program who participate and contribute to the scientific life of the Princess Margaret, but do not already have a formal appointment within the Institute.  Individuals who wish to hold this designation must have the full support of a current Princess Margaret Senior Scientist in good standing.  Affiliate Scientists will have access to institutional resources based on employment agreements reached between them and the Research Director, subject to the approval of the Research Council.

    The Research Appointments Committee will review Affiliate Scientists every 3 years. The criteria for renewal will include evidence of research productivity commensurate with the employment agreement of the affiliate member and evidence for significant interaction with other members of the Institution.

    d) Member of the Cancer Clinical Research Unit (CCRU)
    This category is designated for individuals with combined clinical and research interests, who spend less than 50% of their time devoted to research activities.  Such individuals actively participate in clinical trials, funded both by the peer-reviewed funding agencies and industry. Members of the CCRU are required to align with a Research Division at their hospital site, are full members of respective divisions, and have full access to all of the resources provided by the CCRU.  There is an expectation that all clinical research conducted by the CCRU will strive to meet the highest scientific and ethical standards.

  • Requirements and Procedures for Progression

    Research Appointments Committee
    The Appointments Committee at Princess Margaret is a sub-committee of the Research Council on Oncology (RCO). The role of the Committee is to establish a system of performance review and evaluate individuals to determine whether they are eligible for appointment or renewal. The committee has at least 7 members who serve 3-year terms. The composition of the Committee can be altered from time to time based on recommendations made by the chair of the Appointments Committee as approved by the Research Council.

    Clinical Division Heads may be invited to attend meetings at which a member of their staff is being reviewed.

    Annual Activity Reports
    All appointments to the Research Institute (i.e.: 3-year or 5-year terms at all levels) are contingent upon satisfactory performance as evidence by the Annual Activity Report.  These reports will determine the list of activities undertaken during the preceding calendar year and should include a list of grants, publications, invitations, meetings attended, courses taught and any other academic or scholarly activity.

    Annual Review Process

    i) Annual Activity Reports will be submitted to the Research Institute each year.
    ii) Research Executive Committee members will conduct annual performance reviews for each Scientist in their Division.

    iii) Review recommendations will be submitted to the VP Research. For full-time researchers this annual review process could lead to annual compensation adjustments. If the activity report leads to any concerns, a reasonable action plan with measurable outcomes will be put in place for identified performance areas. Depending on the nature of the issues identified, a review by the VP Research and the Research Appointments Committee could be triggered. Serious cases (e.g. failure to carry on an active, independent, extramurally funded research program) could lead to the loss of the appointment.

    a) Scientist
     The initial appointment is for a 3-year term, pending satisfactory performance as judged by the Research Appointment Committee. In this case, satisfactory performance consists of building a credible cutting edge research program. It is the expectation that the full 3-year term will be completed. Scientists will be subject to the usual principles of employment law, but in addition, major problems, such as failure to submit grants or the failure to undertake experiments would be grounds for dismissal.

    i) First Review (S3)
    Prior to the end of the first term, the candidate must submit the following:

    1. An up-to-date CV.  This should include separate sections with peer-reviewed publications, funding (approved and applied), industry collaborations and current status, awards, invitations (meetings and seminars), and patents from the last three (3) years. Please also supply any other relevant information that shows evidence for the maintenance of a high quality, productive research program. 
    2. Research Plan. Please provide a brief report (not to exceed three (3) pages, single spaced) describing your research progress during the last three-years, your current projects, and your future plans.
    3. References. Please provide the names of at least five (5) potential references (with contact details) in the scientific community familiar with your work.  These people must not have been a supervisor or collaborator.  The Research Appointments Committee will use this list, as well as other sources of information, to acquire letters of assessment. 

    The Committee will review the application and recommend either passing the candidate and grant a second 3-year term or request an interview with the candidate.

    At the interview the candidate will make a short presentation of past progress and future plans and answer questions posed by the Committee. The Committee will act on this information either by recommending that: [1] the candidate pass and be granted a second 3-year term; or [2] the candidate be reviewed again, following the same procedure in 1 year; or [3] that the candidate not be renewed.

    Should a re-review be recommended, the Committee will outline specific goals that must be achieved by the time of the re-review.
    Candidates that are not renewed will be given a working extension term not to exceed 1 year that will allow them reasonable time to find alternative employment, but will not be re-reviewed. All recommendations are brought to the Research Council for final approval.

    ii) Second Review (S6)
    Prior to the end of the second term, the second review is conducted. This review is conducted with the rigor of a tenure review and it is expected that only outstanding candidates will pass.
    The candidate must submit the following:

    1. An up-to-date CV.  This should include separate sections with peer-reviewed publications, funding (approved and applied), industry collaborations and current status, awards, invitations (meetings and seminars), and patents from the last six (6) years. 
    2. Research Plan. Please provide a brief report (not to exceed three (3) pages, single spaced) describing your research progress during the last six (6) years, your current projects, and your future plans.
    3. Top 3 publications.
    4. References. Please provide the names of at least ten (10) potential references (with contact details) in the world-wide scientific community familiar with your work. These people must not have been a supervisor or collaborator. The Research Appointments Committee will use this list, as well as other sources of information, to acquire letters of assessment.
    5. Candidates will also have the option of submitting up to five (5) names of individuals who the candidate does not wish to be reviewed by, including collaborators. Please explain why this person should be excluded.

    The Appointments Committee and an external reviewer will convene a meeting at which the candidate will be asked to present a progress report, outline future directions and respond to questions posed. The Review Committee will recommend either promotion to the Senior Scientist level or not.

    Candidates that fail to be promoted will be given a working extension term (not to exceed 1 year) that will allow them reasonable time to find alternative employment.

    All recommendations are brought to the Research Council for final approval.

    iii) Third Review (S9)
    Normally, Scientists will be eligible for a maximum of two 3 year terms. The Research Council anticipates that, in most cases, 6 years will be sufficient time for the Institute to determine whether progression to the category of Senior Scientist is justified. However, it is recognized that exceptions may occur. Scientists may have lost significant research time because of illness, other Hospital/University activities, parental leave, or other similar legitimate activities that may contribute to their failure to achieve the category of Senior Scientist after two 3-year terms. The Research Council therefore retains the discretion to grant a third 3-year term to a Scientist. The review process in this case will be identical to the second review. Candidates that fail this review will be given a working extension term (not to exceed 1 year) that will allow them reasonable time to find alternative employment.
    All recommendations are brought to the Research Council for final approval.

    b) Senior Scientist (SS5)
    The Committee will review these appointments prior to the end of the term. The Senior Scientist must submit:

    1. An up-to-date CV.  This should include separate sections with peer-reviewed publications, funding (approved and applied), industry collaborations and current status, awards, invitations (meetings and seminars), and patents from the last five (5) years.
    2. Research Plan. Please provide a brief report (not to exceed three (3) pages, single spaced) describing your research progress during the last five (5) years, your current projects, and your future plans.
    3. References. Please provide the names of at least five (5) potential references (with contact details) in the scientific community familiar with your work.  These people must not have been a supervisor or collaborator. The Research Appointments Committee will use this list, as well as other sources of information, to acquire letters of assessment. 

    The Committee will review the application and recommend either awarding the candidate another 5 year term or requesting an interview with the candidate.
    At the interview the candidate will make a short presentation of past progress and future plans and answer questions posed by the Research Appointments Committee. The Research Appointments Committee will act on this information either by recommending that the candidate pass and be granted another 5 year term, or that the candidate be re-reviewed in 2 years.
    After 2 years the candidate will undergo the same process as outlined for the "tenure" (S6) review. The number of external referees will be at the discretion of the Committee. Candidates that fail to pass this review will be given a working extension term that will allow them reasonable time, not to exceed 1 year, to find alternative employment. All recommendations are brought to the Research Council for final approval.

    c) Affiliate Scientist
     The Research Appointments Committee will review Affiliate Scientists every 3 years. The criteria for renewal will include evidence of research productivity commensurate with the employment agreement of the affiliate member and evidence for significant interaction with other members of the Institution.
    The Affiliate Scientist must submit the following:

    1. An up-to-date CV.  This should include separate sections with peer-reviewed publications, funding (approved and applied), industry collaborations and current status, awards, invitations (meetings and seminars), and patents from the last three (3) years.
    2. Research Plan. Please provide a brief report (not to exceed three (3) pages, single spaced) describing your research progress during the last three (3) years, your current projects, and your future plans.
    3. Letter of Support.  Please provide a letter of support from the host Senior Scientist

    Letter requirements:

    • A justification of the candidate’s qualifications
    • Candidate’s current and future salary sources
    • Candidate’s space allocations
    • Commitment to cover resources for reappointment term (3-years)

    The Committee will review the application and recommend either awarding the candidate another 3 year term or terminating the appointment.

  • PM Scientific Standards

    SCIENTIFIC STANDARDS

    THREE-YEAR SCIENTISTS (S3):

    The goal for this period is to establish a successful research program with international impact.

    Candidates will need to achieve a ranking of “A” or “B” to continue on to their 6-Year Scientist review.

     

    Annual Ranking Score

    A.   Outstanding / Excellent

    B. Fully Competent

    C. Unsatisfactory

    Grants:

    At least one major grant that is peer reviewed (eg. CIHR, NCIC, NIH) or from an international foundation.

    One peer reviewed grant (eg. CIHR, NCIC, NIH)

    No peer reviewed grant (eg. CIHR, NCIC, NIH)

    Published Papers*

    - Two “standard” level papers per year with at least one “mid-level” publication within the first three years. A lower number of papers is acceptable if the publications are in an “outstanding” journal.

    - Or, issued patents

    One standard level paper per year (one at mid to outstanding level within the first three years).

    Zero publications in standard level paper per year.

    Evidence of External Impact

    Invitation to at least two lectures at national or international meetings or symposium within the first three years.

    One invitation to give a national or international lecture.

    No invitation to give a national or international lecture.

    Additional factors:

    - Trainees

    At least one graduate student or postdoctoral fellow (co-supervision is acceptable).

    No graduate student or postdoctoral fellow.

    No graduate student or postdoctoral fellow.

     

    SIX-YEAR SCIENTISTS (S6):

    The goal for this period is to develop a world-class research program with the potential of major impact on the field and to demonstrate involvement in the Institute. 

    Candidates must achieve a ranking of “A” in year-6 in order to be promoted to Senior Scientist.

     

    Annual Ranking Score

    A.   Outstanding / Excellent

    B. Fully Competent

    C. Unsatisfactory

    Grants:

    At least two major grants running concurrently that are peer reviewed (eg. CIHR, NCIC, NIH) or from an international foundation.

    One major peer reviewed (eg. CIHR, NCIC, NIH) grant or from an international foundation.

    No peer reviewed grant (eg. CIHR, NCIC, NIH)

    Published Papers*

    - Two “standard” level papers per year with at least one in an “outstanding” level journal in the first six years are expected. A lower number of papers may be acceptable if there are more publications in the “outstanding” category.

    - Or, issued patents

    One standard level paper per year (one at mid to outstanding level).

    Zero publications in standard level paper per year.

    Evidence of External Impact

    Invitation to at least three lectures at national or international meetings or symposium per year.

    Invitation to at least two lectures at national or international meetings or symposium per year.

    Invitation to one lectures at national or international meetings or symposium per year.

    Additional factors:

    - Trainees

     

     

     

    - Determine Leadership to the Institute:

    By supporting its activities and influencing direction, nature and quality of programs.

     

     

    At least two graduate students or postdoctoral fellows and evidence of effective mentorship.

     

    Examples include:

    - Leading a team grant or program project

    - Serving on at least one OCI or UofT SGS Department committee

    - Organizing Symposium

    - Licensing of patents for which candidate is author

    - Significant intellectual or leadership role in clinical study

     

     

    One graduate student or postdoctoral fellow and evidence of effective mentorship.

     

     

    No graduate student or postdoctoral fellow.

     

    SENIOR SCIENTISTS (SS5):

    The goal for this period is to maintain a world-class research program that demonstrates major impact on the field and to be an active contributor to the life of the Institute.

    Candidates must receive an overall average ranking of “A” at time of review in order to pass.

     

    Annual Ranking Score

    A.   Outstanding / Excellent

    B. Fully Competent

    C. Unsatisfactory

    Grants:

    At least two major grants running concurrently that are peer reviewed (eg. CIHR, NCIC, NIH) or from an international foundation.

    One peer reviewed grant (eg. CIHR, NCIC, NIH)

    No peer reviewed grant (eg. CIHR, NCIC, NIH)

    Published Papers*

    - Three publications per year in “standard” level journals with two “mid-levels” and one “outstanding” level per five years. A lower number of papers may be acceptable if there are more publications in the “outstanding” category.

    - Or, issued patents

    Two publications per year in “standard” level journals with one “mid-levels” and/or one “outstanding” level per five years. A lower number of papers may be acceptable if there are more publications in the “outstanding” category.

    One publications per year in “standard” level journals

    Evidence of External Impact

    - Give at least three external invited lectures per year, with at least two at international meetings or symposiums.

    - Should consistently serve on at least one of the following:

    • Major grant peer-review panels (e.g. CIHR, NIH, NCIC)
    • Editorial boards
    • Organizing committees of international meetings
    • Committees for international/national academic societies

    Give at least two external invited lectures per year, with at least one at international meetings or symposiums.

     

    Give at least one external invited lecture per year.

     

    Additional factors:

    - Trainees

    - Determine Leadership to the Institute: By supporting its activities and influencing direction, nature and quality of programs.

    • At least three graduate students or postdoctoral fellows and evidence of effective mentorship.
    • Participation in OCI of UofT SGS Department Committees
    • Leadership of team grants and CFI proposals
    • Serving as Department Chair at Hospital or University level
    • Regular participation in Institute events
    • Teaching at a University of Toronto department
    • Work with the Foundation on fundraising initiatives
    • Community Outreach 
    • Significant intellectual or leadership role in clinical study

    Two or fewer graduate students or postdoctoral fellows.

    One graduate student or postdoctoral fellow.

    * Published papers refer to first, senior or co-corresponding from work done in own laboratory.  The goal is to encourage publications of high quality and high impact. In general this will be reflected by the journal in which the paper is published. Please refer to Appendix A for a rating list of journals, which should serve as a rough guide. Citation index and impact factor will also be taken into account. 

    † By supporting its activities and influencing direction, nature and quality of programs.

     

    Generally:

    Leaves: In the instance that a scientist must take a prolonged amount of time off for sickness, maternity/paternity leave or another equivalent leave, their review will be delayed by the same amount of time as the leave.

    Outcomes after failure:  Candidates who fail to pass their 3-year or 6-year review will be given a  working extension term that will allow them reasonable time, not to exceed one year, at which point they will lose their OCI appointment, financial support from the Institute and space within the Institute.

    Candidates who fail to pass their Senior Scientist review will be re-reviewed in 2 years. After 2 years the candidate will undergo the same process as outlined for the 6 Year Scientist (S6) review. The number of external referees will be at the discretion of the Research Appointments Committee. Candidates that fail to pass this review will be given a working extension term that will allow them reasonable time, not to exceed 1 year, at which point they will lose their OCI appointment, financial support from the Institute and space within the Institute. All recommendations are brought to the Research Council for final approval.

    These are guidelines to accompany the UHN Research Policy and Procedure Manual’s “Requirements and Procedures for Progression” (http://intranet.uhnresearch.ca/institutes/pm).

    PDF of this document can be found here - PDF iconPM_Standards_and_Promotions.pdf

Research Space Committee
Core Facility & Equipments Committee
Updates
  • VOIP Phone Rollout in PM CC - August 2015

    Instructions to set up your new voicemail:

    1. Press the icon on your phone that looks like an envelope
    2. You will be prompted to enter a default PIN: 147258
    3. You will then be asked to record a new name to identify yourself to other callers; follow the prompts to record your first and last name.
    4. You will then have the option to record a personalized greeting; follow the prompts to record a personalized greeting.

    To reset your default voicemail PIN (must be 6 digits long):

    • Enter a new, random 6-digit pin followed by # (Note: the system will not allow you to use a trivial pin e.g.123456)
    • Enter new 6-digit pin again to confirm and press #

    Long Distance Dialing Changes:

    • Long Distance codes will no longer be dialed with a 116 prefix. You will now be required to dial 9+Long Distance Phone Number; wait for the tone and enter in your existing long distance authorization code. For example, you will dial 9-1-519-555-2222, you will then be prompted to enter your authorization code and then the telephone number

    Instructions and Guides:
    7942 Guide 
    8941 and 8945 Guide                   
    Cisco 8945 - Quick start instructions              
    Cisco Unity Phone Menus and Voice Commands           
     

Administrative Tools
Address
Institute Mailing Address:
Princess Margaret Cancer Centre
610 University, Suite 7-504
Toronto, ON M5G 2M9
Telephone : (416) 946-2068
Fax : (416) 946-2287
Documents and Forms
Documents and Forms
Documents and Forms
Documents and Forms
Documents and Forms
Documents and Forms
Documents and Forms
Documents and Forms
Institute Inquiry

Dr. Mitsuhiko Ikura, Interim Director of Princess Margaret (PM) Cancer Centre, can answer your questions regarding research programs and activities at PM Cancer Centre. To read previously answered questions, see the archive.

 

Ask Mitsu a question

Contact

oci@uhnresearch.ca


Research Directorate, Princess Margaret Cancer Centre
610 University Avenue
Toronto, ON
M5G 2M9
CANADA
WWW Banner: 
About Us

The Princess Margaret (PM) Cancer Centre is the largest integrated cancer research, teaching and treatment centre in Canada. Its research institute, formerly known as the Ontario Cancer Institute (OCI), includes internationally recognized researchers, cutting-edge research infrastructure and the Campbell Family Institute for Breast Cancer Research. The Centre focuses on cancer research across various fields including genomics, informatics, molecular biology, signalling, structural biology, health services and biophysics. PM’s laboratories and facilities are primarily located at the Centre itself (610 University Avenue) and at the Princess Margaret Cancer Research Tower (in the MaRS Centre).

PM Cancer Centre’s researchers are grouped into the following categories based on their research program:

  • Biodiscovery & Drug Development
  • Cancer Genomics, Epigenetics & Bioinformatics
  • Immunotherapy
  • Psychosocial Aspects of Cancer
  • Stem Cells in Cancer
  • Tumour biology & Imaging

Contact

oci@uhnresearch.ca


Research Directorate, Princess Margaret Cancer Centre
610 University Avenue
Toronto, ON
M5G 2M9
CANADA